Gynecologic Oncology | Specialty

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

No OS Benefit With Chemoradiotherapy in High-Risk Endometrial Cancer

February 24th 2018

Adjuvant chemotherapy given during and after radiotherapy did not improve 5-year overall survival for patients with high-risk endometrial cancer in the phase III PORTEC-3 trial.

Dr. West on the Future of Treatment for Patients With Gynecologic Malignancies

February 23rd 2018

Lindsay West, MD, gynecologic oncologist, University of North Carolina (UNC) Department of Obstetrics and Gynecology, UNC School of Medicine, discusses the future of treatment for patients with gynecologic malignancies.

Radiation Role Remains Uncertain in High-Risk Endometrial Cancer

February 20th 2018

David G. Mutch, MD, discusses questions surrounding the role of radiation therapy for patients with high-risk endometrial cancer.

Concomitant Chemoradiation Remains Standard in Locally Advanced Cervical Cancer

February 19th 2018

Standard cisplatin-based concomitant chemoradiation induced superior disease-free survival compared with neoadjuvant chemotherapy followed by radical surgery in women with locally advanced squamous cervical cancer.

Dr. Arend on Novel Combination Strategies in Gynecologic Cancer

February 17th 2018

Rebecca C. Arend, MD, assistant professor, UAB School of Medicine, UAB Department of Obstetrics and Gynecology, UAB Comprehensive Cancer Center, discusses novel combination strategies in gynecologic cancer.

Dr. Mutch Discusses Radiation Versus Targeted Therapy in Endometrial Cancer

February 12th 2018

David Mutch, MD, Ira C. and Judith Gall professor, vice chair of obstetrics and gynecology, chief, Division of Gynecologic Oncology, Washington University School of Medicine, Siteman Cancer Center, discusses whether or not a patient with high-risk endometrial cancer should receive external beam radiation therapy.

Dr. Backes on Pelvic Exenteration Surgery in Gynecologic Cancer

February 10th 2018

Floor J. Backes, MD, associate professor at The Ohio State University Comprehensive Cancer Center, discusses pelvic exenteration surgery for patients with gynecologic cancer.

Dr. Arend on the Rationale of Novel Combinations in Gynecologic Cancer

February 10th 2018

Rebecca C. Arend, MD, assistant professor, UAB School of Medicine, UAB Department of Obstetrics and Gynecology, UAB Comprehensive Cancer Center, discusses the rationale behind novel combination strategies for patients with gynecologic cancer.

Immune Checkpoint Combinations Show Promise in Endometrioid Disease

February 10th 2018

Many endometrioid cancers express high RNA levels for multiple immune checkpoints, and this may allow physicians to treat these patients with combination immune therapies.

Dr. West on Quality of Life Challenges in Gynecologic Cancer

February 10th 2018

Lindsay West, MD, gynecologic oncologist, UNC Department of Obstetrics and Gynecology, UNC School of Medicine, discusses the challenges with quality of life for patients with gynecologic cancer.

Dr. Haldorsen on Overcoming Challenges With Imaging in Endometrial Cancer

February 9th 2018

Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, on overcoming challenges with imaging in endometrial cancer.

Study Highlights Impact of Race, Geography on Genetic Variation in Endometrial Cancer

February 9th 2018

An analysis of black women of Caribbean descent with type I or type II endometrial cancer showed that this population expressed significant differences in genetic variations compared with a nationwide population of patients with endometrial cancer.

Dr. Taylor on the Future of Treatments for Endometrial Cancer

February 6th 2018

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the future of treatments for patients with endometrial cancer.

Vaccine Therapy Shows Promise in Cervical Cancer

February 1st 2018

Sharad Ghamande, MD, discusses the findings from GOG/NRG-0265, as well as the impact of vaccines for patients with cervical cancer.

Dr. Coleman on the Role of Ramucirumab in Gynecologic Cancer

January 30th 2018

Robert Coleman, MD, professor in the department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, discusses the role of ramucirumab (Cyramza) in patients with gynecologic cancer.

Obesity Impedes Detection of Cervical Precancer, Increasing Cancer Risk

January 24th 2018

Women with a body mass ≥30 kg/m2 had a greater 5-year risk for cervical cancer than lighter women, possibly due to underdiagnosis of cervical precancer.

Dr. Haldorsen on the Contributions of Imaging in Endometrial Cancer

January 24th 2018

Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the contributions of imaging in endometrial cancer.

Dr. Mahantshetty on Challenges With Concomitant Chemoradiation Trial in Cervical Cancer

January 23rd 2018

Umesh Mahantshetty, MD, MBBS, radiation oncologist, Tata Memorial Hospital, Mumbai, discusses challenges with a trial (NCT00193791) conducted by Tata Memorial Hospital seeking to solidify the impact of concomitant chemoradiation with FIGO stage IIIb squamous cervical cancer.

Dr. Taylor Discusses the Management of Endometrial Cancer

January 18th 2018

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the management of endometrial cancer.

Dr. Hensley on dMRR and MSI-H Testing in Endometrial Cancer

January 17th 2018

Martee L. Hensley, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses DNA mismatch repair deficiency (dMMR) and microsatellite-instability high (MSI-H) testing for patients with endometrial cancer.